Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial In men with prostate cancer, bicalutamide monotherapy increases bone mineral ...
The ongoing Early Prostate Cancer (EPC) programme is investigating the effects of adding bicalutamide 150 mg/day to standard care (radiotherapy, radical prostatectomy or watchful waiting). This study ...
Please provide your email address to receive an email when new articles are posted on . The oral androgen receptor inhibitor enzalutamide significantly reduced the risk for prostate cancer progression ...
Combined modality therapy for stage II and stage III pancreatic carcinoma. Patients with progressive prostate cancer were treated with bicalutamide 200 mg daily. Before treatment, patients' tumors ...
Treatment with Xtandi reduced the risk of progression by 76 percent compared with bicalutamide in men with castration-resistant prostate cancer, according to topline results from the phase 2 STRIVE ...
Enzalutamide reduced the risk of disease progression by 56% in mCRPC patients. Data support the use of enzalutamide instead of bicalutamide in patients with asymptomatic or mildly symptomatic ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — The addition of bicalutamide to radiation therapy significantly improved OS and freedom from ...
Learn everything you need to know about Bicalutamide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...
April 15, 2005 — Tamoxifen can reduce the breast pain and gynecomastia associated with bicalutamide, according to the results of a randomized study published in the April 14 Early Online Publication ...
Ad5-prostate-specific enhancer (PSE)/probasin promoter (PBN) E1A-AR and Ad5 PSE/PBN-E1A-ARC685Y were generated using Ad-Easy system (Stratagene, La Jolla, CA, USA). The E1A-AR chimera includes ...
Review the side-effects of Bicalutamide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Research Report on China's Bicalutamide Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. Bicalutamide, originally developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results